Therapeutic Erythrocytapheresis (TE) versus Phlebotomy (P) in the treatment of Hereditary Hemochromatosis (HH) patients: Preliminary results from an ongoing randomized clinical trial (NCT 00202436)

Transfusion and Apheresis Science

Volumn 40, Issue 2, 2009, Pages 135-136

  Rombout Sestrienkova, Eva ^a   Noord, Paulus A H van ^a   Reuser, Ellen ^a   Heeremans, Judith ^a   Deursen, Cees Th B M van ^b   Janssen, Mirian ^c   Koek, Ger H ^d  

^a Sanquin Bloedbank Regio Zuidoost Nijmegen   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTAPHERESIS; ERYTHROCYTAPHERESIS; ERYTHROCYTE; FERRITIN BLOOD LEVEL; GENETIC DISORDER; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOCHROMATOSIS; HEMOGLOBIN BLOOD LEVEL; HEREDITARY HEMOCHROMATOSIS; HUMAN; INTERMETHOD COMPARISON; IRON BLOOD LEVEL; IRON OVERLOAD; PHLEBOTOMY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 62949218297     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2009.01.008     Document Type: Article

References (1)

1. Rombout-Sestrienkova E., van Noord P.A.H., van Deursen C.Th.B.M., Sybesma B.P.H., Nillesen-Meertens A.E.L., and Koek G.H. Transfusion and Apheresis Science 36 (2007) 61-267